Stock data
Treace Medical Concepts, Inc. (TMCI)
Treace Medical Concepts, Inc. (TMCI) reported revenue of US$212.69M and net income of -US$59.00M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$212.69M | US$169.75M | -US$54.15M | -US$59.00M | — |
| 2024 | US$209.36M | US$168.26M | -US$55.69M | -US$55.74M | — |
| 2023 | US$187.12M | US$151.94M | -US$51.43M | -US$49.53M | — |
| 2022 | US$141.84M | US$116.31M | -US$34.84M | -US$42.81M | — |
| 2021 | US$94.42M | US$77.53M | -US$16.51M | -US$20.55M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$45.38M | -US$15.87M | — |
| 2026-03-31 | US$47.20M | -US$17.96M | — |
| 2025-12-31 | US$62.52M | -US$9.39M | — |
| 2025-09-30 | US$50.21M | -US$16.29M | — |
| 2025-06-30 | US$47.39M | -US$17.40M | — |
| 2025-03-31 | US$52.57M | -US$15.92M | — |
| 2024-12-31 | US$68.71M | -US$0.50M | — |
| 2024-09-30 | US$45.09M | -US$15.36M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.